Joakim Håkansson Selected Research

Biocompatible Materials (Biomaterials)

1/2017

Significantly Accelerated Wound Healing of Full-Thickness Skin Using a Novel Composite Gel of Porcine Acellular Dermal Matrix and Human Peripheral Blood Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joakim Håkansson Research Topics

Disease

8	Infections 11/2023 - 12/2012
8	Neoplasms (Cancer) 06/2023 - 03/2006
7	Wounds and Injuries (Trauma) 01/2023 - 05/2014
6	Breast Neoplasms (Breast Cancer) 06/2023 - 08/2020
6	Communicable Diseases (Infectious Diseases) 01/2019 - 12/2012
3	Soft Tissue Infections 09/2022 - 04/2013
3	Surgical Wound Infection 01/2019 - 05/2014
2	Wound Infection (Wound Infections) 09/2022 - 01/2019
2	Carcinogenesis 03/2006 - 03/2005
1	Sarcoma (Soft Tissue Sarcoma) 04/2024
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Hernia (Hernias) 01/2020
1	Cicatrix (Scar) 01/2020
1	Burns 05/2015
1	Type 2 Diabetes Mellitus (MODY) 11/2011
1	Pathologic Neovascularization 01/2011
1	Glucose Intolerance 07/2009
1	Hyperinsulinism (Hyperinsulinemia) 07/2009
1	Insulinoma 03/2006
1	Neoplasm Metastasis (Metastasis) 03/2006
1	Fibrosarcoma 03/2006
1	Necrosis 10/2004

Drug/Important Bio-Agent (IBA)

8	Antimicrobial PeptidesIBA 01/2023 - 12/2012
4	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2020
3	Adenosine Monophosphate (AMP)IBA 01/2021 - 12/2012
3	Peptides (Polypeptides)IBA 01/2021 - 05/2014
3	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 07/2009 - 03/2005
2	RNA (Ribonucleic Acid)IBA 04/2024 - 08/2020
2	HydrogelsIBA 06/2023 - 01/2019
2	Polysaccharides (Glycans)IBA 06/2023 - 01/2020
2	SolutionsIBA 01/2023 - 05/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2022 - 01/2019
2	Fusidic Acid (Fucithalmic)IBA 09/2022 - 01/2021
2	Hyaluronic Acid (Hyaluronan)IBA 01/2020 - 01/2017
2	hydroxypropylcellulose (hydroxypropyl cellulose)FDA Link 05/2015 - 05/2014
2	Anti-Infective Agents (Microbicides)IBA 05/2014 - 12/2012
1	PolymersIBA 06/2023
1	NanogelsIBA 01/2023
1	Phenobarbital (Luminal)FDA Link 12/2022
1	Local Anti-Infective Agents (Antiseptics)IBA 12/2021
1	TEMPOIBA 07/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	AlginatesIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	GelsIBA 01/2021
1	Fluorouracil (Carac)FDA LinkGeneric 01/2021
1	matrigelIBA 01/2021
1	retapamulin FDA Link 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Hematoxylin (Haematoxylon)IBA 01/2020
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2020
1	Poloxamer (Poloxamer 407)IBA 01/2019
1	Antimicrobial Cationic PeptidesIBA 01/2019
1	Biocompatible Materials (Biomaterials)IBA 01/2017
1	Rosiglitazone (Avandia)FDA Link 11/2011
1	Oxygen (Dioxygen)IBA 01/2011
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 03/2006
1	Insulin (Novolin)FDA Link 10/2004

Therapy/Procedure

3	Therapeutics 01/2021 - 05/2015
1	Fracture Fixation 11/2023
1	Replacement Arthroplasty 11/2023
1	Artificial Skin 09/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Punctures 01/2020
1	Aftercare (After-Treatment) 11/2011